Alteration of tumour response to radiation by interleukin-2 gene transfer

British Journal of Cancer

Volumn 82, Issue 4, 2000, Pages 937-944

  Lee, J ^a   Moran, J P ^a   Fenton, B M ^a   Koch, C J ^b   Frelinger, J G ^a   Keng, P C ^a   Lord, E M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hypoxia; Interleukin 2; Murine tumours; Radiation

Indexed keywords

INTERLEUKIN 2; THY 1 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER CELL CULTURE; CANCER IMMUNOLOGY; CANCER RADIOTHERAPY; CELL SURVIVAL; CLONOGENESIS; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; GENE TRANSFER; HOST CELL; HYPOXIA; IMMUNOGENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; VASCULARIZATION;

EID: 0033953844     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1022     Document Type: Article

References (34)

1. Badalament RA, Cibas ES, Reuter VE, Fair WR and Melamed MR (1987) Flow cytometric analysis of primary adenocarcinoma of the bladder. J Urol 137: 1159-1162
2. Braunschweiger PG, Basrur V, Santos O, Adessa A, Houdek P and Markoe AM (1996) Radioresistance in murine solid tumors induced by interleukin-1. Radiat Res 145: 150-156
3. Cameron RB, Spiess PJ and Rosenberg SA (1990) Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action. J Exp Med 171: 249-263
4. Chadwick KH and Leenhouts HP (1973) A molecular theory of cell survival. Physics Med Biol 18: 78-87.
5. Chang AY and Keng PC (1987) Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle. Cancer Res 47: 4338-4341
6. Chiang CS, Syljuasen RG, Hong JH, Wallis A, Dougherty GJ and McBride WH (1997) Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo. Cancer Res 57: 3899-3903
7. Colombo MP, Ferrari G, Stoppacciaro A, Parenza M, Rodolfo M, Mavilio F and Parmiani G (1991) Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med 173: 889-897
8. Evans SM, Jenkins WT, Joiner B, Lord EM and Koch CJ (1996) 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Res 56: 405-411.
9. Fearon ER, Pardoll DM, Itaya T, Golumbek, P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B and Frost P (1990) Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397-403.
10. Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R and Gilboa E (1990) Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172: 1217-1224
11. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH and Broder GJ (1988) Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Physics 14: 831-838
12. Gerber M, Guichard M, Pioch Y and Dubois JB (1989) The influence of interleukin-2, feeder cells, and timing of irradiation on the radiosensitivity of human T lymphocytes assessed by the colony-forming assay. Radiat Res 120: 164-176
13. Gunning P, Leavitt J, Muscat G, Ng SY and Kedes L (1987) A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci USA 84: 4831-4835
14. Hietanen T, Kellokumpu-Lehtinen P and Pitkanen M (1995) Action of recombinant interferons and interleukin 2 in modulating radiation effects on viability and cytotoxicity of large granular lymphocytes. Int J Radiat Biol 67: 119-126
15. Hill RP (1986) Sensitizers and radiation dose fractionation: results and interpretations. Int J Radiat Oncol Biol Physics 12: 1049-1054
16. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26: 45-50
17. Howell RL and Koch CJ (1980) The disaggregation, separation and identification of cells from irradiated and unirradiated EMT6 mouse tumors. Int J Radiat Oncol Biol Physics 6: 311-318
18. Jaffee EM and Pardoll DM (1997) Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines. Methods 12: 143-153
19. James SE, Arlett CF, Green MH and Bridges BA (1983) Radiosensitivity of human T-lymphocytes proliferating in long term culture. Int J Radiat Biol Related Studies Physics, Chem Med 44: 417-422
20. Koch CJ, Evans SM and Lord EM (1995) Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]: analysis of drug adducts by fluroescent antibodies vs bound radioactivity. Br J Cancer 72: 869-874
21. Kwok TT and Sutherland RM (1992) Cell cycle dependence of epidermal growth factor induced radiosensitization. Int J Radiat Oncol Biol Physics 22: 525-527
22. Ledbetter JA and Herzenberg LA (1979) Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 47: 63-90
23. Lee J, Fenton BM, Koch CJ, Frelinger JG and Lord EM (1998) Interleukin 2 expression by tumor cells alters both the immune response and the tumor microenvironment. Cancer Res 58: 1478-1485
24. Lee J, Siemann DW, Koch CJ and Lord EM (1996) Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts. Int J Cancer 67: 372-378
25. McAdam AJ, Felcher A, Woods ML, Pulaski BA, Hutter EK, Frelinger JG and Lord EM (1994) Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes. J Immunother Emphasis Tumor Immunol 15: 155-164.
26. McAdam AJ, Pulaski BA, Storozynsky E, Yeh KY, Sickel JZ, Frelinger JG and Lord EM (1995) Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor. Cell Immunol 165: 183-192
27. McBride WH, Economou JS, Kuber N, Hong JH, Chiang CS, Syljuasen R, Dougherty ST and Dougherty GJ (1995) Modification of tumor microenvironment by cytokine gene transfer. Acta Oncol 34: 447-451
28. Miller AR, McBride WH, Hunt K and Economou JS (1994) Cytokine-mediated gene therapy for cancer. Ann Surg Oncol 1: 436-450
29. Mor F and Cohen IR (1996) IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2. J Immunol 156: 515-522
30. Moulder JE and Rockwell S (1984) Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Physics 10: 695-712
31. Pulaski BA, Yeh KY, Shastri N, Maltby KM, Penney DP, Lord EM and Frelinger JG (1996) Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex 're-presentation' of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc Natl Acad Sci USA 93: 3669-3674
32. Seki H, Iwai K, Kanegane H, Konno A, Ohta K, Ohta K, Yachie A, Taniguchi N and Miyawaki T (1995) Differential protective action of cytokines on radiation-induced apoptosis of peripheral lymphocyte subpopulations. Cell Immunol 163: 30-36
33. Syljuasen RG, Belldegrun A, Tso CL, Withers HR and McBride WH (1997) Sensitization of renal carcinoma to radiation using alpha Interferon (IFNA) gene transfection. Radiat Res 148: 443-448
34. Yokota T. Arai N, Lee F, Rennick D, Mosmann T and Arai K (1985) Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: expression of T-cell growth-factor activity after transfection of monkey cells. Proc Natl Acad Sci USA 82: 68-72